businesspress24.com - Ceapro Files Statement of Defence
 

Ceapro Files Statement of Defence

ID: 1041058

(firmenpresse) - EDMONTON, ALBERTA -- (Marketwire) -- 09/29/11 -- September 29, 2011 - Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the Company") announced today it and its wholly owned subsidiary, Ceapro Veterinary Products Inc., have filed a Statement of Defence in the Court of Queens Bench of Alberta to defend claims made by AVAC Ltd. ("AVAC"). Pursuant to the Statement of Claim, AVAC alleged damages of $724,500. The amounts claimed relate to a royalty agreement that was entered into in 2005 (the "2005 Agreement"). Pursuant to the 2005 Agreement, AVAC provided project funding of $362,250 for product innovation development in the area of veterinary therapeutics and active ingredients (the "Project") and obligated Ceapro to pay a royalty calculated with reference to sales generated from products developed. "The royalties payable in this agreement have been calculated and paid up to date in accordance with the Agreement and we will vigorously contest this claim", said Gilles Gagnon, acting CEO of Ceapro.

About Ceapro Inc.

Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. To learn more about Ceapro, visit .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Branko Jankovic
Chief Financial Officer
Ceapro Inc.
(780) 917-8376




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  CDRD Ventures to Collaborate with Roche to Translate Medical Discoveries into Novel Therapies for Patients
PharmaGap to Host Investor Conference Call
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 29.09.2011 - 20:00 Uhr
Sprache: Deutsch
News-ID 1041058
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

EDMONTON, ALBERTA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 118 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ceapro Files Statement of Defence
"
steht unter der journalistisch-redaktionellen Verantwortung von

Ceapro Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Ceapro Inc.



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 98


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.